N

    Nephros Inc (NEPH)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $4.28
    -0.27 (-5.93%)

    Market Cap: $49.41M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    63%(19/30)
    Avg Surprise
    +68.53%
    Streak
    8 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.03
    Range$0.03 - $0.03
    1 analysts
    EPS RevisionsNo revisions (7d)
    1
    1
    30d
    EPS Estimate Drift
    90d ago$0.03-16.7%
    60d ago$0.03-16.7%
    30d ago$0.02-33.3%
    7d ago$0.02-22.3%
    Current$0.03
    Revenue Consensus
    $5M
    Range$5M - $6M
    3 analysts
    Dec 31, 2026
    EPS Consensus$0.13
    Range$0.13 - $0.13
    1 analysts
    Revenue Consensus
    $7M
    Range$6M - $7M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.13---
    Sep 26EST
    		-$0.03---
    Jun 26
    		$0.06$0.01+500.00%Beat+200.0%
    Mar 26
    		$0.01$0.01+0.00%Beat-80.0%
    Dec 25
    		$0.01$-0.01+200.00%Beat-66.7%
    Sep 25
    		$0.03$-0.02+250.00%Beat+50.0%
    Jun 25
    		$0.02$-0.02+200.00%Beat+166.7%
    Mar 25
    		$0.05$-0.01+1100.00%Beat+350.0%
    Dec 24
    		$0.03$-0.01+300.00%Beat+150.0%
    Sep 24
    		$0.02$-0.02+200.00%Beat+200.0%
    Jun 24
    		$-0.03$-0.01-200.00%Miss+25.0%
    Mar 24
    		$-0.02$-0.04+50.00%Beat+33.3%
    Dec 23
    		$-0.06$-0.02-200.00%Miss+40.0%
    Sep 23
    		$-0.02N/A+60.00%Beat+93.5%
    Jun 23
    		$-0.04$-0.05+20.00%Beat+66.7%
    Mar 23
    		$-0.03$-0.02-50.00%Miss+85.0%
    Dec 22
    		$-0.10$-0.06-66.67%Miss+9.1%
    Sep 22
    		$-0.31$-0.11-181.82%Miss-158.3%
    Jun 22
    		$-0.12$-0.14+14.29%Beat+0.0%
    Mar 22
    		$-0.20$-0.11-81.82%Miss-81.8%
    Dec 21
    		$-0.11$-0.11+0.00%Beat-37.5%
    Sep 21
    		$-0.12$-0.11-9.09%Miss+14.3%
    Jun 21
    		$-0.12$-0.11-9.09%Miss+36.8%
    Mar 21
    		$-0.11$-0.11+0.00%Beat+15.4%
    Dec 20
    		$-0.08$-0.11+27.27%Beat-300.0%
    Sep 20
    		$-0.14$-0.14+0.00%Beat-40.0%
    Jun 20
    		$-0.19$-0.15-26.67%Miss-35.7%
    Mar 20
    		$-0.13$-0.09-44.44%Miss+27.8%
    Dec 19
    		$-0.02N/A+81.82%Beat+77.8%
    Sep 19
    		$-0.10$-0.10+0.00%Beat-900.0%
    Jun 19
    		$-0.14$-0.18+22.22%Beat-1300.0%
    Mar 19
    		$-0.18$-0.09-100.00%Miss-500.0%
    Dec 18
    		$-0.09N/AN/ABeat-550.0%
    Sep 18
    		$-0.01N/AN/ABeat+0.0%
    Jun 18
    		$-0.01N/AN/ABeat+0.0%
    Mar 18
    		$-0.03N/AN/ABeat-200.0%
    Dec 17
    		$0.02N/AN/ABeat+116.9%
    Sep 17
    		$-0.01N/AN/ABeat+88.9%
    Jun 17
    		$-0.01N/AN/ABeat-
    Mar 17
    		$-0.01N/AN/ABeat-
    Dec 16
    		$-0.12N/AN/ABeat-
    Sep 16
    		$-0.09N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio38.91EV/EBITDA22.90x
    Price/FCF-70.30xFCF Yield-1.42%
    Profitability
    Profit Margin8.38%Operating Margin20.20%
    ROE16.10%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage1068.00x
    Current Ratio4.07xQuick Ratio2.71x
    Trading Statistics
    Beta1.52Avg Volume36.12K
    52-Week High$6.4252-Week Low$2.66

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.37
    SMA 20$4.26
    SMA 50$3.81
    SMA 200$3.92
    EMA 10$4.32
    EMA 20$4.21
    EMA 50$3.93
    EMA 200$3.74

    MACD

    Line: 0.16Signal: 0.19Hist: -0.03

    ADX

    ADX: 21.3+DI: 18.3-DI: 24.7

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down4.0
    PSAR$4.75

    Bollinger Bands

    Upper Band$4.96
    Lower Band$3.57
    %B Position3247%(Upper)
    Band Width0.51

    RSI (14-Day)

    Neutral
    52.8

    Momentum Oscillators

    Stoch %K55.0
    Stoch %D50.5
    Williams %R-54.1
    ROC (10d)-0.9%
    Momentum-0.04
    CCI (20d)8.6
    MFI (14d)38.0

    Volatility Measures

    ATR (14d)$0.39(9.2%)
    StdDev (20d)0.35
    Hist Vol101.4%(High)

    Volume Flow

    VWAP$4.29
    OBV-153.1K
    AD Line-1.2M
    CMF (20d)0.039

    Volume Metrics

    Avg Vol (20d)35.0K
    Vol Ratio1.1x
    VWMA (20d)$4.30

    Pivot Points

    R3$4.86
    R2$4.74
    R1$4.65
    Pivot Point$4.52
    S1$4.43
    S2$4.30
    S3$4.21

    Advanced Oscillators

    TSI12.62
    Ultimate Osc48.7
    KST215.49

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$6.02M$5.21M$4.73M$4.76M$4.42M$4.88M$3.87M$3.52M$3.25M$3.52M$3.25M$3.74M
    Cost of Revenue$1.99M$2.22M$1.97M$1.85M$1.62M$1.72M$1.40M$1.37M$1.34M$1.33M$1.23M$1.55M
    Gross Profit$4.03M$2.99M$2.76M$2.92M$2.79M$3.15M$2.48M$2.15M$1.91M$2.19M$2.02M$2.19M
    Operating Expenses$2.81M$2.90M$2.74M$2.60M$2.55M$2.59M$2.16M$1.94M$2.23M$2.39M$2.67M$2.40M
    R&D$366,000$346,000$395,000$338,000$311,000$295,000$252,000$188,000$254,000$212,000$208,000$205,000
    SG&A$2.42M$2.52M$2.32M$2.23M$2.20M$2.25M$1.87M$1.72M$1.94M$2.14M$2.41M$2.14M
    Operating Income$1.21M$97,000$18,000$314,000$248,000$566,000$317,000$206,000$-317,000$-200,000$-649,000$-203,000
    Interest Income$30,000$32,000$54,000$41,000$31,000$13,000$28,000$20,000$21,000$25,000$28,000$11,000
    Interest Expense$1,000$0$0$0$1,000$8,000$0$0$0$1,000$1,000$0
    Income Before Tax$1.21M$140,000$62,000$340,000$246,000$558,000$364,000$183,000$-289,000$-169,000$-654,000$-182,000
    Income Tax Expense$13,000$0$0$3,000$9,000$0$0$0$0$0$0$0
    Net Income$1.20M$140,000$70,000$337,000$237,000$558,000$318,000$183,000$-289,000$-138,000$-654,000$-182,000
    EBITDA$1.21M$135,000$40,000$333,000$249,000$585,000$371,000$196,000$-275,000$-159,000$-630,000$-137,000
    EBIT$1.18M$108,000$8,000$299,000$216,000$545,000$336,000$163,000$-310,000$-193,000$-681,000$-193,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NEPH

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    0
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Nephros, Inc. Delivers Record Quarter Amid Margin Strain

    Nephros, Inc. reported record Q2 2026 revenue of $6.0M, a 36% year-over-year increase, and significantly higher profitability, with net income rising over 400%. The company emphasized strong operational execution and long-term growth confidence, despite facing margin pressures from tariffs, foreign exchange, and freight costs, and acknowledged that a one-time tariff refund boosted gross margins. Weak operating cash flow due to increased accounts receivable and inventory, along with rising operating expenses for growth, were also noted.

    The Globe and Mail•8/25/26•
    Somewhat-Bullish

    Wexford Capital adds Nephros (NEPH) shares in cashless option move

    Wexford Capital LP has acquired 812 net shares of Nephros (NEPH) common stock through a cashless exercise of stock options, bringing their direct holdings to 56,872 shares. The transaction involved exercising options for 3,765 shares at $3.60 each, with a portion withheld to cover the exercise price. After this move, Wexford Capital still holds 36,198 stock options set to expire on August 24, 2026.

    Stock Titan•8/20/26•
    Neutral

    Benchmark reiterates Speculative Buy on Nephros stock after Q2 beat By Investing.com

    Benchmark has reiterated its Speculative Buy rating and a $6.00 price target for Nephros (NASDAQ:NEPH) after the company reported strong second-quarter results. Nephros exceeded revenue and earnings expectations with $6.0 million in revenue (up 36% year-over-year) and earnings of $0.11 per share. The positive performance was attributed to higher programmatic product sales, service revenue, and a significant tariff refund.

    Investing.com India•8/18/26•
    Bullish

    Nephros (NEPH) director Arthur Amron granted 2,418 shares, holds 140,874

    Nephros Inc. director Arthur H. Amron was granted 2,418 shares of Common Stock on August 12, 2026, as compensation for his board service, increasing his direct holdings to 140,874 shares. He also holds stock options for 7,323 shares fully vested at an exercise price of $2.14 per share, and options for an additional 7,050 shares at $1.47 per share, vesting in three equal installments from 2025 to 2027. This transaction was reported in a Form 4 SEC filing, indicating a neutral impact and sentiment.

    Stock Titan•8/14/26•
    Neutral

    Northland Securities Maintains Nephros(NEPH.US) With Hold Rating, Raises Target Price to $4.75

    Northland Securities has reiterated its Hold rating on Nephros (NEPH.US) but raised the price target to $4.75. This adjustment indicates a slightly more optimistic outlook on the company's future stock performance by the firm.

    Moomoo•8/14/26•
    Somewhat-Bullish

    Frequently Asked Questions About NEPH

    Does NEPH pay dividends?
    Nephros Inc (NEPH) does not currently pay a regular dividend.
    What is NEPH's P/E ratio?
    Nephros Inc has a price-to-earnings (P/E) ratio of 38.91.
    What is NEPH's market cap?
    Nephros Inc (NEPH) has a market capitalization of $49.41M with a current stock price of $4.28.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In